
Sign up to save your podcasts
Or
Neuralink gets approval to start human trials in Canada, The New York Times says OpenAI deleted evidence in its copyright lawsuit, and Chemists have created the world's thinnest spaghetti. It has a medical use. It's Thursday, November 22nd and this is Engadget News.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
4.6
1717 ratings
Neuralink gets approval to start human trials in Canada, The New York Times says OpenAI deleted evidence in its copyright lawsuit, and Chemists have created the world's thinnest spaghetti. It has a medical use. It's Thursday, November 22nd and this is Engadget News.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
1,644 Listeners
723 Listeners
1,398 Listeners
972 Listeners
138 Listeners
69 Listeners
986 Listeners
497 Listeners
960 Listeners
174 Listeners
42 Listeners
5,924 Listeners
7 Listeners
137 Listeners
3,289 Listeners